Quantcast

Latest Fluticasone/salmeterol Stories

2010-12-06 10:00:00

BURLINGTON, Mass., Dec. 6, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim/Pfizer's Spiriva will most likely strengthen its position among the sales leaders for the treatment of chronic obstructive pulmonary disease (COPD) through greater use in the primary care setting. GlaxoSmithKline's Advair and Spiriva are the sales leaders in the COPD market, and hold similar...

2010-12-01 00:33:35

Office-based primary care doctors rank GSK's sales force number one, a jump from third in 2009. Pfizer finished second and Merck placed third this year. Plymouth Meeting, PA (Vocus) November 30, 2010 According to SDI's 2010 Ranking Tables Study, office-based primary care physicians "“ general practitioners, family medicine physicians, and doctors of osteopathy "“ rank GlaxoSmithKline's sales force number one, a jump from third in 2009. Pfizer finished second and Merck placed...

2010-11-15 10:37:00

PHOENIX, Nov. 15, 2010 /PRNewswire-FirstCall/ -- Despite national guidelines recommending that inhaled corticosteroid (ICS) be used alone as the preferred treatment for patients with mild persistent asthma, a new study finds that nearly two-thirds of these patients are taking more costly drugs that combine an ICS and a long-acting beta agonist (LABA) - with no apparent additional clinical benefit noted based on pharmacy and medical claims. The analysis was conducted by the Medco Research...

2010-11-01 21:30:13

Benefits outweigh risks for asthmatics, but COPD patients should think twice Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics. "These medications are very effective...

2010-08-31 08:45:00

BURLINGTON, Mass., Aug. 31 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, through 2019, an expanding aging population and increases in diagnosis and drug treatment will fuel steady 4.6 percent annual growth in the chronic obstructive pulmonary disease (COPD) drug market. The Pharmacor 2010 findings from the topic entitled Chronic Obstructive Pulmonary Disease reveal that the COPD drug...

2010-08-24 10:30:00

WALTHAM, Mass., Aug. 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that some surveyed physicians indicate that they will decrease their overall prescribing of long-acting beta2 agonists (LABA)/inhaled corticosteroids (ICS) combination therapies over the next 12 months for the treatment of asthma in response to the U.S. Food and Drug Administration's new safety controls for LABA-containing...

2010-07-16 13:22:00

SILVER SPRING, Md., July 16 /PRNewswire-USNewswire/ -- The FDA is warning the public that certain Advair Diskus inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Advair Diskus (fluticasone propionate and salmeterol inhalation powder)...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related